Early Detection of Ototoxicity Using Serial Mobile Audiometry, Otoacoustic Emissions Testing, and Inner Ear Biomarker Measurement in Patients Receiving Platinum-Based Chemotherapy Treatment: It is Feasible to Implement in a National Health Service (N
High compliance with serial mobile audiometry and otoacoustic emissions testing, and serum biomarker measurement suggests that ototoxicity monitoring can be successfully performed in cancer ambulatory care rather than in an audiology department setting. Further investigation is required to understand the role of serum prestin and otolin-1 in monitoring ototoxicity.
Authors
- Marina Forbes (ORCID: https://orcid.org/0000-0002-0753-297X)
- Eleftheria Iliadou (ORCID: https://orcid.org/0000-0003-2586-7551)
- Nishchay Mehta (ORCID: https://orcid.org/0000-0001-9317-3055)
- Constantine Alifrangis (ORCID: https://orcid.org/0000-0002-5876-6696)
- Rachael Windsor (ORCID: https://orcid.org/0000-0002-9614-0811)
- Roulla Katiri (ORCID: https://orcid.org/0000-0001-7098-8024)
- Tanjinah Ferdous (ORCID: https://orcid.org/0000-0002-1736-4287)
- Leah Ensell
- Anne G.M. Schilder
- Helen Lowe
- Asma Awad
Institutions
- University College London Hospitals NHS Foundation Trust (GB)
- National Institute for Health and Care Research (GB)
- CRUK Lung Cancer Centre of Excellence (GB)
- University College London (GB)
Publication Details
- Journal
- Otology & Neurotology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1097/mao.0000000000004856
- Primary Topic
- Hearing, Cochlea, Tinnitus, Genetics
- Type
- article
- Field-Weighted Citation Impact
- 0.00